Prognosis Evaluation
Prognosis Evaluation - Related Videos
10:03
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
0 Views •
Cited by 2 •
2020
Development of major adverse cardiovascular events, which impact cardiovascular prognosis after coronary angioplasty, are influenced by the extent of coronary damage and vascular repair. The use of novel coronary cellular and soluble biomarkers, reactive to vascular damage and repair, are useful to predict the development of MACEs and prognosis.
08:25
A Rat Graft Rejection Model of Intestinal Transplantation with Exteriorized Ileostomy for Longitudinal Prognosis Assessment
0 Views •
2025
This protocol describes a rat-based intestinal transplantation model with ileostomy for time-course assessment of drug intervention on graft rejection.
08:04
Evaluating the Accuracy of Snap Judgments
0 Views •
2023
Source: Diego Reinero & Jay Van Bavel—New York University Social psychologists have long been interested in the way people form impressions of others. Much of this work has focused on the errors people make in judging others, such as the exaggerated influence of central traits (such as "warm" and "cold"), the insufficient weight given to the context in which others' behavior takes place, and the tendency for people to make judgments that conform to their initial expectations about another.
03:00
Self-Evaluation: Self-Enhancement and Self-Verification
0 Views •
2020
Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...
06:15
Evaluation of Bioenergetic Function in Cerebral Vascular Endothelial Cells
0 Views •
Cited by 11 •
2016
Endothelial cell mitochondria are critical to maintain blood-brain-barrier integrity. We introduce a protocol to measure bioenergetic function in cerebral vascular endothelial cells.
FAQs
The estimate depends on the interaction of clinical findings, disease characteristics, patient-specific factors, and diagnostic results. Evidence from comparable cases can provide context, but it does not eliminate individual variation. Considering these elements together helps clinicians avoid relying on a single finding and produces a more appropriately individualized assessment of likely progression, treatment response, and recovery.
A patient’s condition and the available clinical evidence can change over time, so an initial estimate may no longer represent current risks or expected outcomes. Regular reassessment incorporates new findings and updated responses to treatment. This dynamic approach allows clinicians to revise expectations, adjust care planning, and communicate more relevant information as the disease course develops.
Comparable cases provide an evidence-based reference for estimating possible disease courses, outcomes, and treatment responses. Their value is greatest when clinicians interpret them alongside the patient’s own findings and characteristics rather than treating group experience as a guaranteed prediction. This comparison supports more informed risk assessment while preserving recognition of differences between individuals.
Prognostic information helps clinicians weigh expected disease progression, potential recovery, and likely response to available treatment approaches. These estimates can support selection of a strategy that fits the patient’s clinical circumstances and anticipated course. Because prognosis is not static, treatment decisions may need reconsideration when new diagnostic information or changes in condition alter the assessment.
The anticipated disease course and estimated risks help determine how closely a patient should be monitored and what follow-up may be needed. As the patient’s condition changes, clinicians can reassess the prognosis and modify the follow-up plan accordingly. This links ongoing observation to current clinical information rather than relying solely on the original assessment.
Prognostic estimates give clinicians a structured basis for discussing expected progression, possible outcomes, and treatment response with patients and families. They also support shared decisions by connecting medical evidence with the patient’s circumstances and preferences. Communication should acknowledge uncertainty and individual variation, while regular updates ensure that expectations reflect the most current assessment.